Objective: To identify any change in quality of life (QoL) caused by chemotherapy-induced
toxicities, such as hearing loss and tinnitus, to provide information in order to improve …

Cisplatin-induced ototoxicity results in significant, permanent hearing loss in pediatric and
adult cancer survivors. Elucidating the mechanisms underlying cisplatin-induced hearing …

Routine examination includes history, physical examination, chest X‑ray, and examination
under anesthesia with endoscopy, if indicated. Computed tomography and/or magnetic …

Background: Cisplatin is an extensively used anti-neoplastic agent for the treatment of
various solid tumors. However, a high incidence of severe ototoxicity is accompanied by its …

Background Head and neck cancer (HNC) treatment can cause oral morbidities, such as
oral dryness and dysphagia, affecting the patient's quality of life (QOL). The relationship …

The treatment of oral cavity cancer primarily depends on the location, tumor size, and
feasibility of organ preservation in patients with negative margins. A liquid biopsy is a …

Background Concurrent chemoradiotherapy using weekly cisplatin remains standard of care
for locally advanced cervical cancer in Sub-Saharan Africa. While cisplatin remains a …

Purpose: Head and neck cancer (HNC) patients experience various posttreatment side
effects that decrease quality of life (QOL). Some previous study reported that QOL of HHC …

Background: Rural post-treatment head and neck cancer (HNC) survivors experience high
rates of cancer-related distress and may experience unique symptom clusters. Oncology …

Objective Highlight the novelties of cisplatin ototoxicity and its prevention, focussing on the
role of oxidative stress. Methods We screened various electronic databases and selected …